SCHEMBL406816

SCHEMBL406816

Cc1cc(OP(Oc2cc(C)c(C(C)(C)C)cc2C(C)(C)C)Oc2cc(C)c(C(C)(C)C)cc2C(C)(C)C)c(C(C)(C)C)cc1C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34
ADRA2A P08913 1/20 0.33
ADRA2C P18825 1/20 0.33
ADRA1D P25100 1/20 0.33
ADRA1A P35348 1/20 0.33
ADRA1B P35368 1/20 0.33
CYP1A2 P05177 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
ALDH1A1 P00352 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CA2 P00918 1/20 0.31
POLB P06746 1/20 0.31
TYR P14679 1/20 0.31
KDM4E B2RXH2 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29373209 1.00 ALOX15 (0.34) ALOX15LMNATP53CYP3A4HPGD
SCHEMBL30770673 0.98 LMNA (0.33) ALOX15LMNATP53CYP3A4HPGD
SCHEMBL9007666 0.89 LMNA (0.31) ALOX15LMNATP53CYP3A4HPGD
SCHEMBL26698111 0.87 LMNA (0.30) ALOX15LMNATP53CYP3A4HPGD
SCHEMBL15133340 0.87 KDM4E (0.38) ALOX15HPGDCYP2C19ALDH1A1SMN1; SMN2
SCHEMBL30816714 0.87 KDM4E (0.38) ALOX15HPGDCYP2C19ALDH1A1SMN1; SMN2
SCHEMBL14423397 0.86 LMNA (0.33) ALOX15LMNATP53CYP3A4HPGD
SCHEMBL11129316 0.84 ALOX15 (0.36) ALOX15LMNATP53CYP3A4HPGD
SCHEMBL7949644 0.84 LMNA (0.32) ALOX15LMNATP53CYP3A4HPGD
SCHEMBL31572308 0.84 ALOX15 (0.36) ALOX15LMNATP53CYP3A4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2796495-B1 METHOD OF PRODUCING OLEFIN RESIN COMPOSITION ADEKA CORP (JP) 2018-07-04 EP claimed
US-8183311-B2 Liquid phosphite composition derived from cresols CHEMTURA CORPORATION (US) 2012-05-22 US claimed
WO-2011014211-A1 LIQUID PHOSPHITE COMPOSITION DERIVED FROM META-CRESOLS CHEMTURA CORPORATION (US) 2011-02-03 WO claimed
US-20100076125-A1 LIQUID PHOSPHITE COMPOSITION DERIVED FROM CRESOLS CHEMTURA CORPORATION (US) 2010-03-25 US claimed
EP-0516006-B1 4,4'-Biphenylenediphosphonite compound and use thereof YOSHITOMI PHARMACEUTICAL (JP) 1996-10-23 EP claimed
US-20260139087-A1 COMPOUND, POLYMER, LIGHT STABILIZER COMPOSITION, RESIN COMPOSITION, COATING MATERIAL COMPOSITION, ARTICLE, SEALING MATERIAL, MOLDED ARTICLE, METHOD FOR PRODUCING WEATHER-RESISTANT RESIN COMPOSITION, AND METHOD FOR IMPROVING WEATHER RESISTANCE OF SYNTHETIC RESIN ADEKA CORPORATION (JP) 2026-05-21 US disclosed
EP-4745198-A1 RESIN COMPOSITION, MOLDED ARTICLE, RESIN ADDITIVE COMPOSITION, METHOD FOR PRODUCING RESIN COMPOSITION, METHOD FOR IMPROVING CRYSTALLINITY OF CRYSTALLINE RESIN, AND MATERIAL FOR RESIN ADDITIVE COMPOSITION ADEKA CORPORATION (JP) 2026-05-20 EP disclosed
US-20260002014-A1 RESIN COMPOSITION AND MOLDED ARTICLE THEREOF ADEKA CORPORATION (JP) 2026-01-01 US disclosed
US-20260001067-A1 CATALYTIC REACTION METHOD, METHOD FOR PRODUCING ORGANIC COMPOUND, AND CATALYST COMPOSITION NITTO DENKO CORP (JP) 2026-01-01 US disclosed
US-12466938-B2 Resin additive composition, thermoplastic resin composition, and molded article thereof ADEKA CORPORATION (JP) 2025-11-11 US disclosed
WO-2025228825-A1 FILM COMPRISING POLYETHYLENE SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2025-11-06 WO disclosed
US-12441065-B2 Formed article, welding method, and method of manufacturing formed article ASAHI KASEI KABUSHIKI KAISHA (JP) 2025-10-14 US disclosed
EP-0516006-A1 4,4'-Biphenylenediphosphonite compound and use thereof YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1992-12-02 EP disclosed
US-4829110-A OXIDATION RESISTANCE TO BLEACHES AND DETERGENTS SOLVAY & CIE (SOCIETE ANONYME) (BE) 1989-05-09 US disclosed
US-4806580-A CHROMAN DERIVATIVE, ORGANIC PHOSPHATE OR/AND ORGANIC PHOSPHONATES; DISCOLORATION INHIBITION BASF AKTIENGESELLSCHAFT (DE) 1989-02-21 US disclosed
EP-0263524-A2 Stabilizer compositions for plastics BASF Aktiengesellschaft (DE) 1988-04-13 EP disclosed
US-4670493-A OXIDATION RESISTANCE; PHENOLIC ANTIOXIDANT, PHOSPHONITE, SULF UR-CONTAINING STABILIZER SOLVAY & CIE (SOCIETE ANONYME) (BE) 1987-06-02 US disclosed
EP-0091152-B1 STABILIZED COMPOSITIONS OF ALPHA-OLEFINIC POLYMERS SOLVAY & Cie (Société Anonyme) (BE) 1986-02-19 EP disclosed
US-4348308-A IMPROVING COLOR STABILITY OF VINYL CHLORIDE POLYMERS ADEKA ARGUS CHEMICAL CO., LTD. (JP) 1982-09-07 US disclosed
US-4282141-A DISCOLORATION INHIBITION FOR VINYL CHLORIDE POLYMERS ARGUS CHEMICAL CORPORATION (US) 1981-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260002014-A1 RESIN COMPOSITION AND MOLDED ARTICLE THEREOF NXF1, NOP2, RTF1 ALOX15 1049/4885LMNA 1042/4885TP53 2495/4885
US-20260139087-A1 COMPOUND, POLYMER, LIGHT STABILIZER COMPOSITION, RESIN COMPOSITION, COATING MATERIAL COMPOSITION, ARTICLE, SEALING MATERIAL, MOLDED ARTICLE, METHOD FOR PRODUCING WEATHER-RESISTANT RESIN COMPOSITION, AND METHOD FOR IMPROVING WEATHER RESISTANCE OF SYNTHETIC RESIN SEM1, RAD51, SUN2 ALOX15 704/4885LMNA 1525/4885TP53 4365/4885
US-20260001067-A1 CATALYTIC REACTION METHOD, METHOD FOR PRODUCING ORGANIC COMPOUND, AND CATALYST COMPOSITION HAO2, SCO2, PC ALOX15 62/4885LMNA 4433/4885TP53 2085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.